Pharmacist-led pain management in home-based cancer patients under the medical consortium model: a prospective randomized controlled trial
Supportive Care in Cancer · 2026-01 · 34 (1)
DOI: 10.1007/s00520-025-10255-9 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Supportive Care in Cancer, 2026-01. Verfasst von Xiao Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, Jiangsu, China. Hauptthemen laut MEDLINE: Pharmacists, Cancer Pain, Pain Management, Home Care Services. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Jiangsu Pharmaceutical Association-Tianqing Pharmaceutical Special Research Fund.
Themen: Schmerzmanagement, Onkologische Pflege
Abstract (Originalsprache)
OBJECTIVE: To evaluate the effectiveness of pharmacist-led medication therapy management services (MTMs) in managing cancer pain for home-based patients under a medical consortium model. METHODS: A prospective randomized controlled trial was conducted involving 100 discharged cancer patients with moderate-to-severe pain. Participants were randomly assigned to either the MTMs intervention group or the conventional care group. Outcome measures, including pain scores, pain relief levels, medication adherence, and anxiety levels, were assessed at 24 h after admission (baseline), 7 days, 1 month, and 3 months of follow-up. RESULTS: After 3 months, both groups exhibited significant reductions in pain scores compared to the 24-h baseline (P < 0.01). However, the intervention group demonstrated significantly lower pain scores (3.54 ± 0.76 vs 4.50 ± 1.18) and higher pain relief rates (CR + PR: 36.0% vs 12.0%). The proportion of patients with poor adherence in the intervention group was significantly lower than that of the control group (P < 0.01), and the improvement rate in medication adherence was significantly higher (50% vs 6%, P < 0.01). Furthermore, the intervention group showed a lower level of anxiety (P < 0.01) and a greater improvement in anxiety (38% vs 12%, P < 0.01). CONCLUSION: The implementation of standardized MTMs by pharmacists within the medical consortium effectively extended pharmaceutical care to the home setting. This intervention improved pain relief, enhanced medication adherence, and reduced anxiety among cancer pain patients; these findings support the potential for broader clinical application of this pharmacist-led model within integrated healthcare systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, Jiangsu, China.
- Department of Pharmacy, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, China. dengxu0828@163.com.
Förderung
- Jiangsu Pharmaceutical Association-Tianqing Pharmaceutical Special Research Fund
Zitieren
APA
Li, X., Sun, Y., Sun, R., Zhang, P., & Deng, X. (2026). Pharmacist-led pain management in home-based cancer patients under the medical consortium model: a prospective randomized controlled trial. Supportive Care in Cancer. https://doi.org/10.1007/s00520-025-10255-9
Vancouver
Li X, Sun Y, Sun R, Zhang P, Deng X. Pharmacist-led pain management in home-based cancer patients under the medical consortium model: a prospective randomized controlled trial. Supportive Care in Cancer. 2026. doi:10.1007/s00520-025-10255-9
BibTeX
@article{Li2026,
author = {Li, Xiao and Sun, Ying and Sun, Ruidong and Zhang, Panpan and Deng, Xu},
title = {Pharmacist-led pain management in home-based cancer patients under the medical consortium model: a prospective randomized controlled trial},
journal = {Supportive Care in Cancer},
year = {2026},
doi = {10.1007/s00520-025-10255-9}
}
EUVIMED